A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I

NCT01142700 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus Genotype 1

Interventions

DRUG: BMS-824393
DRUG: BMS-824393
DRUG: BMS-824393
DRUG: Placebo
DRUG: Peginterferon Alpha-2a
DRUG: Ribavirin

Sponsor

Bristol-Myers Squibb